Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease

Alzheimer's disease (AD) can present with atypical clinical forms where the prominent domain of deficit is not memory, that is, atypical AD. Atypical AD patients show cortical atrophy on MRI, hypometabolism on [18F]fluorodeoxyglucose (FDG) PET, tau uptake on [18F]AV‐1451 PET, and white matter tract degeneration on diffusion tensor imaging (DTI). How these disease processes relate to each other locally and distantly remains unclear. We aimed to examine multimodal neuroimaging relationships in individuals with atypical AD, using univariate and multivariate techniques at region‐ and voxel‐level. Forty atypical AD patients underwent MRI, FDG‐PET, tau‐PET, beta‐amyloid PET, and DTI. Patients were all beta‐amyloid positive. Partial Pearson's correlations were performed between tau and FDG standardized uptake value ratios, gray matter MRI‐volumes and white matter tract fractional anisotropy. Sparse canonical correlation analysis was applied to identify multivariate relationships between the same quantities. Voxel‐level associations across modalities were also assessed. Tau showed strong local negative correlations with FDG metabolism in the occipital and frontal lobes. Tau in frontal and parietal regions was negatively associated with temporoparietal gray matter MRI‐volume. Fractional anisotropy in a set of posterior white matter tracts, including the splenium of the corpus callosum, cingulum, and posterior thalamic radiation, was negatively correlated with parietal and occipital tau, atrophy and, predominantly, with hypometabolism. These results support the view that tau is the driving force behind neurodegeneration in atypical AD, and that a breakdown in structural connectivity is related to cortical neurodegeneration, particularly hypometabolism.

[1]  K Patterson,et al.  Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. , 2000, Brain : a journal of neurology.

[2]  B. Miller,et al.  Classification of primary progressive aphasia and its variants , 2011, Neurology.

[3]  W. Jagust,et al.  Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia , 2008, Annals of neurology.

[4]  Clifford R. Jack,et al.  FDG PET and MRI in Logopenic Primary Progressive Aphasia versus Dementia of the Alzheimer’s Type , 2013, PloS one.

[5]  Vladimir Fonov,et al.  VoxelStats: A MATLAB Package for Multi-Modal Voxel-Wise Brain Image Analysis , 2016, Front. Neuroinform..

[6]  B. Miller,et al.  White matter damage in primary progressive aphasias: a diffusion tensor tractography study. , 2011, Brain : a journal of neurology.

[7]  Daniel R. Schonhaut,et al.  Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. , 2016, Brain : a journal of neurology.

[8]  Brian B. Avants,et al.  Dementia induces correlated reductions in white matter integrity and cortical thickness: A multivariate neuroimaging study with sparse canonical correlation analysis , 2010, NeuroImage.

[9]  C. Jack,et al.  11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. , 2008, Brain : a journal of neurology.

[10]  B. Miller,et al.  The logopenic/phonological variant of primary progressive aphasia , 2008, Neurology.

[11]  Gereon R Fink,et al.  In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.

[12]  C. Jack,et al.  Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study , 2012, The Lancet Neurology.

[13]  Paul M. Thompson,et al.  Improved DTI registration allows voxel-based analysis that outperforms Tract-Based Spatial Statistics , 2014, NeuroImage.

[14]  J. Molinuevo,et al.  Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease , 2011, Neurology.

[15]  Brian B. Avants,et al.  Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain , 2008, Medical Image Anal..

[16]  Clifford R. Jack,et al.  Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum , 2017, Cortex.

[17]  C. Jack,et al.  Imaging correlates of posterior cortical atrophy , 2007, Neurobiology of Aging.

[18]  R. Tibshirani,et al.  A penalized matrix decomposition, with applications to sparse principal components and canonical correlation analysis. , 2009, Biostatistics.

[19]  Keith A. Johnson,et al.  Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease , 2017, JAMA neurology.

[20]  W. M. van der Flier,et al.  Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease. , 2016, Brain : a journal of neurology.

[21]  C. Jack,et al.  Elevated occipital β-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasia , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  H. Mayberg,et al.  Correction of PET Data for Partial Volume Effects in Human Cerebral Cortex by MR Imaging , 1990, Journal of computer assisted tomography.

[23]  Arthur W. Toga,et al.  Human brain white matter atlas: Identification and assignment of common anatomical structures in superficial white matter , 2008, NeuroImage.

[24]  Robert I. Reid,et al.  Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study. , 2015, Journal of Alzheimer's disease : JAD.

[25]  Clifford R. Jack,et al.  Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease , 2018, Alzheimer's & Dementia.

[26]  C. Jack,et al.  Temporoparietal atrophy: A marker of AD pathology independent of clinical diagnosis , 2011, Neurobiology of Aging.

[27]  Daniel R. Schonhaut,et al.  Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease , 2017, NeuroImage: Clinical.

[28]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[29]  Gereon R. Fink,et al.  Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease , 2016, Annals of clinical and translational neurology.

[30]  G. Chételat,et al.  Region-Specific Hierarchy between Atrophy, Hypometabolism, and β-Amyloid (Aβ) Load in Alzheimer's Disease Dementia , 2012, The Journal of Neuroscience.

[31]  Keith A. Johnson,et al.  Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease , 2018, JAMA neurology.

[32]  R. Petersen,et al.  Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy , 2004, Neurology.

[33]  Nick C Fox,et al.  White matter tract signatures of the progressive aphasias , 2013, Neurobiology of Aging.

[34]  Brian B. Avants,et al.  The optimal template effect in hippocampus studies of diseased populations , 2010, NeuroImage.

[35]  C. Jack,et al.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.

[36]  Brian B. Avants,et al.  Sparse canonical correlation analysis relates network-level atrophy to multivariate cognitive measures in a neurodegenerative population , 2014, NeuroImage.

[37]  Karl J. Friston,et al.  Unified segmentation , 2005, NeuroImage.

[38]  Luca Passamonti,et al.  Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy , 2018, Brain : a journal of neurology.

[39]  Gereon R Fink,et al.  NETWORKS OF TAU DISTRIBUTION IN ALZHEIMER’S DISEASE , 2017, Alzheimer's & Dementia.

[40]  David T. Jones,et al.  Defining imaging biomarker cut points for brain aging and Alzheimer's disease , 2017, Alzheimer's & Dementia.

[41]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[42]  Daniel R. Schonhaut,et al.  Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy , 2015, Annals of neurology.

[43]  M. Gorno-Tempini,et al.  White matter atrophy in Alzheimer's disease variants , 2012, Alzheimer's & Dementia.

[44]  G. Chételat,et al.  Regional patterns of gray matter volume, hypometabolism, and beta-amyloid in groups at risk of Alzheimer's disease , 2017, Neurobiology of Aging.

[45]  Peter R. Martin,et al.  Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease. , 2018, Journal of Alzheimer's disease : JAD.

[46]  V. Lowe,et al.  Clinical, FDG and amyloid PET imaging in posterior cortical atrophy , 2015, Journal of Neurology.

[47]  J. Phillips,et al.  18F-Flortaucipir PET/MRI Correlations in Nonamnestic and Amnestic Variants of Alzheimer Disease , 2017, The Journal of Nuclear Medicine.

[48]  Nick C Fox,et al.  Posterior cortical atrophy , 2012, The Lancet Neurology.

[49]  H. Hotelling Relations Between Two Sets of Variates , 1936 .

[50]  Massimo Filippi,et al.  White Matter Degeneration in Atypical Alzheimer Disease. , 2015, Radiology.

[51]  W. Jagust,et al.  Relationships Between Tau and Glucose Metabolism Reflect Alzheimer's Disease Pathology in Cognitively Normal Older Adults. , 2019, Cerebral cortex.